Comprehensive genomic sequence analysis, mutation stability assessment, and OECD-compliant ethical committee reports for regulatory submissions.
From sequence input to regulatory-ready ethical committee reports. OECD-compliant genomics and immunogenicity assessment.
Production-grade bioinformatics pipelines for therapeutic protein development and regulatory submissions.
Full-length sequence alignment, variant identification, functional annotation, and codon optimization for expression systems.
ΔΔG predictions with FoldX and Rosetta. Structural impact analysis, aggregation propensity, and thermal stability profiling.
Gene ontology, pathway enrichment, protein domain analysis, and clinical variant interpretation for therapeutic targets.
T-cell epitope prediction, MHC-II binding affinity, and immunogenic hotspot mapping for biologics development.
Custom NGS analysis, RNA-seq, variant calling, pathway enrichment, and statistical analysis with publication-ready figures.
OECD-compliant reports covering genomics, immunogenicity, and biosafety assessment for regulatory submissions.
Request a custom genomics analysis for your therapeutic protein. OECD-compliant ethical committee documentation. Turnaround: 10-14 days.